Investigation of the Efficacy and Safety of JTT-751in Hemodialysis Patients

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220681

Enrollment

168

Registered

2009-03-03

Start date

2009-03-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

investigational material(s) Generic name etc : JTT-751 INN of investigational material : Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational mate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic renal failure undergoing hemodialysis 3 times a week

Exclusion criteria

Exclusion criteria: Patients with gastrointestinal diseases, such as peptic ulcer etc. Patients with advanced cardiac disease or hepatic dysfunction etc.

Design outcomes

Primary

Measure	Time frame
Efficacy, Safety	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026